Incidence and predictors of pericardial effusion after chemoradiation therapy for locally advanced non-small cell lung cancer
Purpose Findings from Radiation Therapy Oncology Group (RTOG) 0617 suggested that
collateral radiation to the heart may contribute to early death in patients receiving …
collateral radiation to the heart may contribute to early death in patients receiving …
Doses of radiation to the pericardium, instead of heart, are significant for survival in patients with non-small cell lung cancer
Background and purpose Higher cardiac dose was associated with worse overall survival in
the RTOG0617 study. Pericardial effusion (PCE) is a common cardiac complication of …
the RTOG0617 study. Pericardial effusion (PCE) is a common cardiac complication of …
Cardiac events after radiation therapy: combined analysis of prospective multicenter trials for locally advanced non–small-cell lung cancer
Purpose Radiation therapy is a critical component in the care of patients with non–small-cell
lung cancer (NSCLC), yet cardiac injury after treatment is a significant concern. Therefore …
lung cancer (NSCLC), yet cardiac injury after treatment is a significant concern. Therefore …
Probing thoracic dose patterns associated to pericardial effusion and mortality in patients treated with photons and protons for locally advanced non-small-cell lung …
Purpose To investigate thoracic dose–response patterns for pericardial effusion (PCE) and
mortality in patients treated for locally advanced Non-Small-Cell Lung Cancer (NSCLC) by …
mortality in patients treated for locally advanced Non-Small-Cell Lung Cancer (NSCLC) by …
Predicting adverse cardiac events after radiotherapy for locally advanced non–small cell lung cancer
Background Radiotherapy may cause grade≥ 3 cardiac events, necessitating a better
understanding of risk factors. The potential predictive role of imaging biomarkers with …
understanding of risk factors. The potential predictive role of imaging biomarkers with …
Cardiac toxicity after radiotherapy for stage III non–small-cell lung cancer: pooled analysis of dose-escalation trials delivering 70 to 90 Gy
K Wang, MJ Eblan, AM Deal, M Lipner… - Journal of Clinical …, 2017 - ascopubs.org
Purpose The significance of radiotherapy (RT)–associated cardiac injury for stage III non–
small-cell lung cancer (NSCLC) is unclear, but higher heart doses were associated with …
small-cell lung cancer (NSCLC) is unclear, but higher heart doses were associated with …
Risk factors for pericardial effusion in inoperable esophageal cancer patients treated with definitive chemoradiation therapy
X Wei, HH Liu, SL Tucker, S Wang, R Mohan… - International Journal of …, 2008 - Elsevier
PURPOSE: To identify clinical and dosimetric factors influencing the risk of pericardial
effusion (PCE) in patients with inoperable esophageal cancer treated with definitive …
effusion (PCE) in patients with inoperable esophageal cancer treated with definitive …
Cardiac radiation dose, cardiac disease, and mortality in patients with lung cancer
KM Atkins, B Rawal, TL Chaunzwa, N Lamba… - Journal of the American …, 2019 - jacc.org
Background: Radiotherapy-associated cardiac toxicity studies in patients with locally
advanced non–small cell lung cancer (NSCLC) have been limited by small sample size and …
advanced non–small cell lung cancer (NSCLC) have been limited by small sample size and …
Heart dosimetric analysis of three types of cardiac toxicity in patients treated on dose-escalation trials for Stage III non-small-cell lung cancer
K Wang, KA Pearlstein, ND Patchett, AM Deal… - Radiotherapy and …, 2017 - Elsevier
Background and purpose To assess associations between radiation dose/volume
parameters for cardiac subvolumes and different types of cardiac events in patients treated …
parameters for cardiac subvolumes and different types of cardiac events in patients treated …
Dosimetric predictors of cardiotoxicity in thoracic radiotherapy for lung cancer
JF Borkenhagen, C Bergom, CT Rapp… - Clinical Lung Cancer, 2019 - Elsevier
Background Higher cardiac radiotherapy (RT) doses when treating lung cancer are
associated with worse overall survival (OS), although the direct association between cardiac …
associated with worse overall survival (OS), although the direct association between cardiac …
相关搜索
- pericardial effusion chemoradiation therapy
- lung cancer mortality in patients
- pericardial effusion lung cancer
- lung cancer radiation therapy
- cancer patients chemoradiation therapy
- lung cancer dosimetric predictors
- risk factors chemoradiation therapy
- pericardial effusion risk factors
- lung cancer cardiac toxicity
- pericardial effusion photons and protons
- pericardial effusion dose patterns
- pericardial effusion mortality in patients
- cardiac events radiation therapy
- combined analysis radiation therapy
- lung cancer photons and protons
- lung cancer dose patterns